Glaxo reports Lucozade sales pressure
Drug maker GlaxoSmithKline today said sales of its Lucozade drink slumped 12% as it announced lower quarterly profits amid slumping US performance.
The pharmaceuticals giant said its sports and energy drinks suffered as UK consumers shied away from impulse buys.
The Business Hub
Newsletter
News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.





